Alaaeldin Bashier - Concepedia

Author

Alaaeldin Bashier

Also Known As

A. Bashier, A., Bashier, ALAAELDIN BASHIER, Adnan Bashier, Alaa Eldin Bashier, AlaaEldin Bashier, Alaaeldeen Bashier, Alaaeldin Bashier, Alaaeldin M Bashier, Alaaeldin M. Bashier

Publications

711

Citations

H-Index

Concepts

All Affiliations

Dubai Hospital Dubai Health Authority Rashid Hospital Dubai Medical College Tawam Hospital

About

Alaaeldin Bashier is an author at Dubai Hospital specializing in diabetes, medicine, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	171
2	Diabetes	7	7	200
3	Public Health	5	5	159
4	Global Health	2	2	82
5	Endocrinology	1	1	17

Alaaeldin Bashier

Publications

353

Citations

H-Index

Page 1

	Year	Citations
Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2-I) During the Month of Ramadan in Muslim Patients with Type 2 Diabetes Alaaeldin Bashier, Azza Khalifa, Elamin Abdelgadir, Oman Medical Journal	2018	48
The role of optimum diabetes care in form of Ramadan focused diabetes education, flash glucose monitoring system and pre-Ramadan dose adjustments in the safety of Ramadan fasting in high risk patients with diabetes Mohamed Hassanein, Elamin Abdelgadir, Alaaeldin Bashier, Diabetes Research and Clinical Practice Metabolic SyndromeDiabetes ManagementHealth PolicyGlobal HealthDiabetes	2019	46
The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care Fatheya Alawadi, Fouzia Rashid, Alaaeldin Bashier, Diabetes Research and Clinical Practice ObesityMetabolic SyndromeNutritionDiabetes ManagementHealth Policy	2019	37
Emirates Diabetes Society Consensus Guidelines for the Management of Type 2 Diabetes Mellitus – 2020 Fatheya Alawadi, Salah Abusnana, Bachar Afandi, Dubai Diabetes and Endocrinology Journal United Arab EmiratesCardiometabolic RiskSocioeconomic DevelopmentSociety Consensus GuidelinesObesity	2020	36
Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in Emirati Patients With Type 2 Diabetes Alaaeldin Bashier, Azza Khalifa, Fouzia Rashid, Journal of Clinical Medicine Research	2017	28
Use of flash glucose monitoring system in assessing safety of the SGLT2 inhibitors during Ramadan fasting in high risk insulin treated patients with type 2 diabetes Elamin Abdelgadir, Fouzia Rashid, Alaaeldin Bashier, Diabetes & Metabolic Syndrome Clinical Research & Reviews Metabolic SyndromeDiabetes ManagementHigh Risk InsulinMedicineInsulin Management	2019	28
A prospective multi-country observational trial to compare the incidences of diabetic ketoacidosis in the month of Ramadan, the preceding month, and the following month (DKAR international) Elamin Abdelgadir, Mohamed Hassanein, Alaaeldin Bashier, Journal of Diabetes & Metabolic Disorders	2016	25
Impact of optimum diabetes care on the safety of fasting in Ramadan in adult patients with type 2 diabetes mellitus on insulin therapy Alaaeldin Bashier, Azza Khalifa Bin Hussain, Fatheya Alawadi, Diabetes Research and Clinical Practice ObesityMetabolic SyndromeDiabetes ManagementInsulin ManagementDiabetes	2019	21
Liraglutide effect in reducing HbA1c and weight in Arab population with type2 diabetes, a prospective observational trial Alaaeldin Bashier, Azza Abdulaziz Khalifa Bin Hussain, Elamin Ibrahim Elamin Abdelgadir, Journal of Diabetes & Metabolic Disorders	2015	20
Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus Fatheya Alawadi, Maryam Alsaeed, Fawzi Bachet, Diabetes Research and Clinical Practice ObesityMetabolic SyndromeType 1Diabetes ManagementAdolescent Patients	2020	19

Page 1